Amphotericin B inhibits entry of Leishmania donovani into primary macrophages

Biochemical and Biophysical Research Communications

Volumn 399, Issue 3, 2010, Pages 429-433

  Paila, Yamuna Devi ^a   Saha, Bhaskar ^b   Chattopadhyay, Amitabha ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Amphotericin B; Cholesterol; Leishmania donovani; Lipid receptor interactions; Primary macrophages

Indexed keywords

AMPHOTERICIN B; CHOLESTEROL; ERGOSTEROL;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL INTERACTION; FEMALE; HOST; IN VIVO STUDY; LEISHMANIA DONOVANI; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROMASTIGOTE; VISCERAL LEISHMANIASIS;

AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; FEMALE; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C;

LEISHMANIA DONOVANI; PROTOZOA;

EID: 77956123575     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.07.099     Document Type: Article

References (43)

1. Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R.W., Alvar J., Boelaert M. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat. Rev. Microbiol. 2007, 5:873-882.
2. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 2004, 27:305-318.
3. Wolday D., Berhe N., Akuffo H., Britton S. Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol. Today 1999, 15:182-187.
4. Alexander J., Satoskar A.R., Russell D.G. Leishmania species: models of intracellular parasitism. J. Cell Sci. 1999, 112:2993-3002.
5. Rittig M.G., Bogdan C. Leishmania-host-cell interaction: complexities and alternative views. Parasitol. Today 2000, 16:292-297.
6. Mouritsen O.G., Zuckermann M.J. What's so special about cholesterol?. Lipids 2004, 39:1101-1113.
7. Simons K., Ikonen E. How cells handle cholesterol. Science 2000, 290:1721-1726.
8. Mukherjee S., Maxfield F.R. Membrane domains. Annu. Rev. Cell Dev. Biol. 2004, 20:839-866.
9. Simons K., Ehehalt R. Cholesterol, lipid rafts, and disease. J. Clin. Invest. 2002, 110:597-603.
10. Riethmüller J., Riehle A., Grassmé H., Gulbins E. Membrane rafts in host-pathogen interactions. Biochim. Biophys. Acta 2006, 1758:2139-2147.
11. Pucadyil T.J., Chattopadhyay A. Cholesterol: a potential therapeutic target in Leishmania infection?. Trends Parasitol. 2007, 23:49-53.
12. Burger K., Gimpl G., Fahrenholz F. Regulation of receptor function by cholesterol. Cell. Mol. Life Sci. 2000, 57:1577-1592.
13. Pucadyil T.J., Chattopadhyay A. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog. Lipid Res. 2006, 45:295-333.
14. Paila Y.D., Chattopadhyay A. Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell. Biochem. 2010, 51:439-466.
15. Pucadyil T.J., Tewary P., Madhubala R., Chattopadhyay A. Cholesterol is required for Leishmania donovani infection: implications in leishmaniasis. Mol. Biochem. Parasitol. 2004, 133:145-152.
16. Tewary P., Veena K., Pucadyil T.J., Chattopadhyay A., Madhubala R. The sterol-binding antibiotic nystatin inhibits entry of non-opsonized Leishmania donovani into macrophages. Biochem. Biophys. Res. Commun. 2006, 339:661-666.
17. Rodríguez N.E., Gaur U., Wilson M.E. Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages. Cell. Microbiol. 2006, 8:1106-1120.
18. Wasan K.M., Wasan E.K., Gershkovich P., Zhu X., Tidwell R.R., Werbovetz K.A., Clement J.G., Thornton S.J. Highly effective oral amphotericin B formulation against murine visceral leishmaniasis. J. Infect. Dis. 2009, 200:357-360.
19. Cohen B.E., Ramos H., Gamargo M., Urbina J. The water and ionic permeability induced by polyene antibiotics across plasma membrane vesicles from Leishmania sp. Biochim. Biophys. Acta 1986, 860:57-65.
20. Hartsel S., Bolard J. Amphotericin B: new life for an old drug. Trends Pharmacol. Sci. 1996, 17:445-449.
21. Readio J.D., Bittman R. Equilibrium binding of amphotericin B and its methyl ester and borate complex to sterols. Biochim. Biophys. Acta 1982, 685:219-224.
22. Mouri R., Konoki K., Matsumori N., Oishi T., Murata M. Complex formation of amphotericin B in sterol-containing membranes as evidenced by surface plasmon resonance. Biochemistry 2008, 47:7807-7815.
23. Ramos H., Valdivieso E., Gamargo M., Dagger F., Cohen B.E. Amphotericin B kills unicellular leishmanias by forming aqueous pores permeable to small cations and anions. J. Membr. Biol. 1996, 152:65-75.
24. M. Vermeersch, R.I. da Luz, K. Toté, J.-P. Timmermans, P. Cos, L. Maes, In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences, Antimicrob. Agents Chemother. 53 (2009) 3855-3859.
25. Saha B., Nanda-Roy H., Pakrashi A., Chakrabarti R.N., Roy S. Immunobiological studies on experimental visceral leishmaniasis. I. Changes in lymphoid organs and their possible role in pathogenesis. Eur. J. Immunol. 1991, 21:577-581.
26. Wadhone P., Maiti M., Agarwal R., Kamat V., Martin S., Saha B. Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response. J. Immunol. 2009, 182:7146-7154.
27. Paila Y.D., Pucadyil T.J., Chattopadhyay A. The cholesterol-complexing agent digitonin modulates ligand binding of the bovine hippocampal serotonin 1A receptor. Mol. Membr. Biol. 2005, 22:241-249.
28. Mosser D.M., Edelson P.J. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. J. Immunol. 1985, 135:2785-2789.
29. Butcher B.A., Sklar L.A., Seamer L.C., Glew R.H. Heparin enhances the interaction of infective Leishmania donovani promastigotes with mouse peritoneal macrophages. A fluorescence flow cytometric analysis. J. Immunol. 1992, 148:2879-2886.
30. Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties?. Biochim. Biophys. Acta 1986, 864:257-304.
31. Gimpl G., Wiegand V., Burger K., Fahrenholz F. Cholesterol and steroid hormones: modulators of oxytocin receptor function. Prog. Brain Res. 2002, 139:43-55.
32. Harrison T., Samuel B.U., Akompong T., Hamm H., Mohandas N., Lomasney J.W., Haldar K. Erythrocyte G protein-coupled receptor signaling in malarial infection. Science 2003, 301:1734-1736.
33. Edidin M. Shrinking patches and slippery rafts: scales of domains in the plasma membrane. Trends Cell Biol. 2001, 11:492-496.
34. Munro S. Lipid rafts: elusive or illusive?. Cell 2003, 115:377-388.
35. Jacobson K., Mouritsen O.G., Anderson R.G.W. Lipid rafts: at a crossroad between cell biology and physics. Nat. Cell Biol. 2007, 9:7-14.
36. van der Goot F.G., Harder T. Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin. Immunol. 2001, 13:89-97.
37. Gatfield J., Pieters J. Essential role for cholesterol in entry of Mycobacteria into macrophages. Science 2000, 288:1647-1650.
38. Naroeni A., Porte F. Role of cholesterol and the ganglioside GM1 in entry and short-term survival of Brucella suis in murine macrophages. Infect. Immun. 2002, 70:1640-1644.
39. Seveau S., Bierne H., Giroux S., Prévost M.C., Cossart P. Role of lipid rafts in E-cadherin- and HGF-R/Met-mediated entry of Listeria monocytogenes into host cells. J. Cell Biol. 2004, 166:743-753.
40. Berman J. Current treatment approaches to leishmaniasis. Curr. Opin. Infect. Dis. 2003, 16:397-401.
41. Murray H.W. Treatment of visceral leishmaniasis in 2004. Am. J. Trop. Med. Hyg. 2004, 71:787-794.
42. Saha A.K., Mukherjee T., Bhaduri A. Mechanism of action of amphotericin B on Leishmania donovani promastigotes. Mol. Biochem. Parasitol. 1986, 19:195-200.
43. Berman J.D., Hanson W.L., Chapman W.L., Alving C.R., Lopez-Berestein G. Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrob. Agents Chemother. 1986, 30:847-851.